ONABOTULINUMTOXINA

ONABOTULINUMTOXINA was reported 77970 times

ONABOTULINUMTOXINA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MEPHISTO SIGN 52 0.7324
1 BROW PTOSIS 449 0.6845
2 MULTIPLE USE OF SINGLE-USE PRODUCT 2866 0.5100
3 BOTULISM 398 0.4807
4 EYELID SENSORY DISORDER 75 0.3807
5 FACE LIFT 20 0.3226
6 EYELID PTOSIS 3149 0.3096
7 FACIAL PARESIS 943 0.2662
8 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 27 0.2596
9 FACIAL ASYMMETRY 245 0.2568
10 POSTNATAL GROWTH RESTRICTION 30 0.2290
11 LAGOPHTHALMOS 83 0.2029
12 RESIDUAL URINE VOLUME INCREASED 21 0.1780
13 PRODUCT PREPARATION ERROR 3646 0.1773
14 CERVICOGENIC HEADACHE 24 0.1765
15 PINEAL GLAND CYST 19 0.1357
16 SKIN WRINKLING 331 0.1216
17 PRODUCT PREPARATION ISSUE 751 0.1144
18 AUTONOMIC DYSREFLEXIA 17 0.1049
19 NEUROMUSCULAR TOXICITY 35 0.0994
20 LID SULCUS DEEPENED 34 0.0912
21 SKIN INDENTATION 43 0.0911
22 FACIAL DISCOMFORT 60 0.0846
23 CUTIS LAXA 21 0.0772
24 VESTIBULAR MIGRAINE 18 0.0747
25 THERAPEUTIC RESPONSE DECREASED 4513 0.0744
26 MIGRAINE WITHOUT AURA 22 0.0733
27 FACIAL SPASM 77 0.0688
28 MUSCLE HYPERTROPHY 23 0.0655
29 SKIN TIGHTNESS 299 0.0635
30 INCORRECT PRODUCT FORMULATION ADMINISTERED 54 0.0610
31 POST-TRAUMATIC NECK SYNDROME 41 0.0507
32 OCCIPITAL NEURALGIA 28 0.0496
33 POOR QUALITY PRODUCT ADMINISTERED 521 0.0494
34 INJECTION SITE OEDEMA 83 0.0483
35 SKIN LAXITY 21 0.0479
36 EXTRAOCULAR MUSCLE PARESIS 22 0.0479
37 HYPOAESTHESIA EYE 28 0.0475
38 DROPPED HEAD SYNDROME 18 0.0456
39 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1588 0.0437
40 SOFT TISSUE INJURY 32 0.0423
41 EYELID FUNCTION DISORDER 33 0.0417
42 TORTICOLLIS 88 0.0415
43 FACIAL PARALYSIS 344 0.0403
44 MASTICATION DISORDER 121 0.0395
45 PERIORBITAL SWELLING 218 0.0385
46 INJECTION SITE HYPOAESTHESIA 55 0.0384
47 MANUFACTURING PRODUCT SHIPPING ISSUE 20 0.0368
48 FACIAL PAIN 318 0.0356
49 EYELID DISORDER 81 0.0351
50 EYELID OEDEMA 408 0.0351
51 PHARYNGEAL HYPOAESTHESIA 32 0.0344
52 THERAPEUTIC RESPONSE SHORTENED 1133 0.0341
53 HYPOAESTHESIA FACIAL 50 0.0333
54 PRODUCT TEMPERATURE EXCURSION ISSUE 161 0.0313
55 INJECTION SITE PARAESTHESIA 48 0.0312
56 BLEPHAROSPASM 193 0.0306
57 EYE CONTUSION 64 0.0303
58 OPHTHALMOPLEGIA 47 0.0298
59 LIP DISORDER 56 0.0295
60 VIITH NERVE PARALYSIS 102 0.0295
61 TENSION HEADACHE 123 0.0286
62 PRODUCT USED FOR UNKNOWN INDICATION 35 0.0278
63 FACIAL PALSY 58 0.0268
64 TONGUE PARALYSIS 19 0.0267
65 SWELLING OF EYELID 161 0.0256
66 MIGRAINE 2406 0.0252
67 STERNAL FRACTURE 31 0.0251
68 SENSATION OF PRESSURE 22 0.0249
69 ASTHENOPIA 132 0.0240
70 POOR QUALITY DRUG ADMINISTERED 151 0.0233
71 PERIORBITAL OEDEMA 120 0.0231
72 BLADDER SPASM 43 0.0229
73 REDUCED FACIAL EXPRESSION 23 0.0227
74 SUSPECTED PRODUCT QUALITY ISSUE 41 0.0224
75 TONGUE MOVEMENT DISTURBANCE 19 0.0222
76 PATIENT DISSATISFACTION WITH TREATMENT 42 0.0218
77 GESTATIONAL HYPERTENSION 28 0.0217
78 COUNTERFEIT PRODUCT ADMINISTERED 28 0.0215
79 POSTURE ABNORMAL 67 0.0206
80 NECK PAIN 1141 0.0204
81 DRUG INEFFECTIVE 26774 0.0203
82 DIPLOPIA 522 0.0201
83 CYSTITIS NONINFECTIVE 26 0.0194
84 DYSPHAGIA 1731 0.0182
85 STRABISMUS 53 0.0180
86 DARK CIRCLES UNDER EYES 26 0.0177
87 INJECTION SITE PAPULE 79 0.0172
88 EYE SWELLING 641 0.0172
89 SWELLING FACE 1116 0.0171
90 MUSCLE TIGHTNESS 267 0.0165
91 HEAD DISCOMFORT 290 0.0164
92 VOCAL CORD PARALYSIS 29 0.0162
93 INJECTION SITE INDENTATION 35 0.0161
94 ABNORMAL SENSATION IN EYE 69 0.0160
95 MUSCULAR WEAKNESS 1820 0.0160
96 SEDATION 415 0.0158
97 LIBIDO INCREASED 32 0.0158
98 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 21 0.0155
99 ONYCHOMADESIS 65 0.0155
100 EYELID PAIN 31 0.0152
101 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 835 0.0152
102 TRIGEMINAL NEURALGIA 61 0.0152
103 HYPERACUSIS 56 0.0150
104 PARALYSIS 215 0.0150
105 MAST CELL ACTIVATION SYNDROME 21 0.0150
106 INJECTION SITE RASH 457 0.0149
107 HYPERTONIC BLADDER 43 0.0149
108 THERAPEUTIC RESPONSE DELAYED 41 0.0146
109 ELECTRIC SHOCK SENSATION 41 0.0146
110 INJECTION SITE SWELLING 1117 0.0146
111 PRODUCT DISTRIBUTION ISSUE 130 0.0140
112 TRISMUS 72 0.0139
113 TEMPOROMANDIBULAR JOINT SYNDROME 36 0.0135
114 OFF LABEL USE 11721 0.0134
115 INJECTION RELATED REACTION 22 0.0133
116 MUSCLE TWITCHING 307 0.0133
117 PRODUCT STORAGE ERROR 1139 0.0130
118 THERAPEUTIC PRODUCT EFFECT VARIABLE 50 0.0129
119 EXCESSIVE EYE BLINKING 19 0.0128
120 INJECTION SITE INFLAMMATION 64 0.0128
121 MUSCLE CONTRACTIONS INVOLUNTARY 45 0.0128
122 PHOTOPHOBIA 240 0.0127
123 PREGNANCY 254 0.0127
124 SUSPECTED COUNTERFEIT PRODUCT 50 0.0126
125 MUSCLE ATROPHY 160 0.0126
126 PERSONALITY DISORDER 33 0.0126
127 HEAD TITUBATION 17 0.0123
128 MUSCLE SPASTICITY 151 0.0123
129 HYPOAESTHESIA ORAL 185 0.0123
130 HOSTILITY 31 0.0122
131 LIVE BIRTH 102 0.0122
132 DROOLING 84 0.0121
133 INJECTION SITE NODULE 133 0.0121
134 INJECTION SITE DISCOMFORT 127 0.0121
135 FACET JOINT SYNDROME 39 0.0120
136 NIGHTMARE 413 0.0119
137 NEUROGENIC BLADDER 25 0.0118
138 CONCUSSION 90 0.0116
139 THERAPEUTIC PRODUCT EFFECT DECREASED 516 0.0115
140 MIGRAINE WITH AURA 31 0.0114
141 URINARY BLADDER HAEMORRHAGE 24 0.0114
142 PARANASAL SINUS DISCOMFORT 43 0.0113
143 NERVE INJURY 126 0.0113
144 INJECTION SITE PAIN 3468 0.0113
145 TERMINAL INSOMNIA 20 0.0113
146 AURA 21 0.0112
147 RHEUMATIC FEVER 50 0.0112
148 NECK SURGERY 26 0.0112
149 VOCAL CORD DISORDER 22 0.0111
150 BLADDER PAIN 35 0.0110
151 EAR DISCOMFORT 112 0.0109
152 ATROPHY 21 0.0108
153 URINARY RETENTION 360 0.0108
154 OCULAR DISCOMFORT 119 0.0106
155 NASAL OEDEMA 19 0.0105
156 INFLUENZA LIKE ILLNESS 858 0.0104
157 INCORRECT STORAGE OF DRUG 18 0.0104
158 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 741 0.0104
159 SENSATION OF HEAVINESS 40 0.0103
160 ONYCHOMYCOSIS 45 0.0102
161 EYE MOVEMENT DISORDER 69 0.0101
162 DRY EYE 498 0.0100
163 INJECTION SITE HYPERSENSITIVITY 31 0.0099
164 VISION BLURRED 1359 0.0099
165 INJECTION SITE SCAR 28 0.0098
166 GENERAL PHYSICAL CONDITION ABNORMAL 66 0.0097
167 EYE DISCHARGE 101 0.0097
168 MUSCLE DISORDER 78 0.0096
169 SWOLLEN JOINT COUNT INCREASED 30 0.0094
170 EYE OEDEMA 23 0.0094
171 GUILLAIN-BARRE SYNDROME 45 0.0093
172 INJECTION SITE URTICARIA 226 0.0092
173 MASS 127 0.0091
174 SPEECH DISORDER 475 0.0091
175 LIP PAIN 26 0.0090
176 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 165 0.0090
177 MONOPLEGIA 39 0.0090
178 DRUG ADMINISTERED AT INAPPROPRIATE SITE 94 0.0089
179 SENSORY DISTURBANCE 143 0.0089
180 CHOKING SENSATION 49 0.0089
181 INJECTION SITE INFECTION 29 0.0088
182 AMYOTROPHIC LATERAL SCLEROSIS 19 0.0088
183 THROAT TIGHTNESS 237 0.0088
184 ERYTHEMA OF EYELID 47 0.0087
185 LACRIMATION INCREASED 262 0.0087
186 AUTONOMIC NERVOUS SYSTEM IMBALANCE 25 0.0085
187 PHYSICAL DECONDITIONING 22 0.0085
188 MUSCLE FATIGUE 36 0.0085
189 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1722 0.0085
190 DEEP VEIN THROMBOSIS POSTOPERATIVE 17 0.0085
191 MATERNAL EXPOSURE DURING BREAST FEEDING 34 0.0084
192 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 143 0.0083
193 INFUSION SITE BRUISING 18 0.0083
194 THERAPEUTIC PRODUCT EFFECT DELAYED 38 0.0083
195 PRE-EXISTING CONDITION IMPROVED 52 0.0083
196 PERIPHERAL VENOUS DISEASE 34 0.0083
197 EYE INJURY 25 0.0082
198 INJECTION SITE MASS 303 0.0082
199 ENDOMETRIAL CANCER 18 0.0082
200 NEPHROLITHIASIS 374 0.0081
201 PARESIS 18 0.0081
202 NEURALGIA 195 0.0080
203 HYPOTONIA 80 0.0080
204 DYSPHONIA 467 0.0080
205 FINE MOTOR SKILL DYSFUNCTION 23 0.0079
206 OCCUPATIONAL EXPOSURE TO PRODUCT 51 0.0079
207 EXOPHTHALMOS 17 0.0079
208 SKIN MASS 52 0.0078
209 BRAIN FOG 120 0.0076
210 CHOKING 149 0.0076
211 BRUXISM 41 0.0076
212 SENSATION OF FOREIGN BODY 64 0.0076
213 DYSARTHRIA 283 0.0075
214 TENDERNESS 78 0.0075
215 INJECTION SITE VESICLES 45 0.0074
216 SPINAL FUSION SURGERY 30 0.0074
217 BURNING SENSATION 516 0.0074
218 HYPOAESTHESIA 1098 0.0073
219 MYASTHENIA GRAVIS 59 0.0073
220 NODULE 95 0.0073
221 LIP SWELLING 241 0.0072
222 FOREIGN BODY SENSATION IN EYES 46 0.0072
223 IMPAIRED DRIVING ABILITY 82 0.0072
224 EYE PAIN 406 0.0072
225 URINARY INCONTINENCE 213 0.0072
226 VASODILATATION 18 0.0071
227 AREFLEXIA 19 0.0071
228 EYE DISORDER 234 0.0071
229 EYELIDS PRURITUS 22 0.0071
230 RHINALGIA 19 0.0069
231 MADAROSIS 80 0.0069
232 SKIN DISORDER 229 0.0069
233 PRODUCT SUPPLY ISSUE 49 0.0069
234 PANIC REACTION 49 0.0068
235 EYELID IRRITATION 17 0.0068
236 VERTIGO 412 0.0068
237 INFUSION SITE REACTION 20 0.0067
238 INJECTION SITE HAEMATOMA 97 0.0067
239 HEADACHE 4135 0.0066
240 TINNITUS 302 0.0066
241 AUTOIMMUNE DISORDER 64 0.0066
242 SINUS HEADACHE 39 0.0066
243 EAR PAIN 127 0.0065
244 SWELLING 611 0.0065
245 PANIC ATTACK 237 0.0065
246 MUSCULOSKELETAL STIFFNESS 568 0.0065
247 BLEPHARITIS 26 0.0065
248 PRODUCT CONTAMINATION 23 0.0065
249 IMPAIRED WORK ABILITY 138 0.0064
250 ASPIRATION 70 0.0064
251 PARAESTHESIA ORAL 92 0.0064
252 VISUAL FIELD DEFECT 46 0.0064
253 DEAFNESS UNILATERAL 35 0.0063
254 JOINT RANGE OF MOTION DECREASED 85 0.0063
255 PERONEAL NERVE PALSY 36 0.0063
256 SPINAL OPERATION 78 0.0063
257 PAIN IN JAW 178 0.0063
258 PHARYNGEAL DISORDER 18 0.0062
259 PRODUCT ADMINISTRATION INTERRUPTED 49 0.0062
260 DRY MOUTH 506 0.0062
261 JAW DISORDER 34 0.0062
262 LUMBAR SPINAL STENOSIS 18 0.0062
263 BLADDER DISORDER 61 0.0061
264 INCORRECT PRODUCT STORAGE 80 0.0061
265 AUTOIMMUNE THYROIDITIS 23 0.0061
266 CONTUSION 584 0.0061
267 PRODUCT CONTAINER ISSUE 52 0.0061
268 SPINAL STENOSIS 25 0.0061
269 FIBROMYALGIA 147 0.0060
270 HORDEOLUM 26 0.0060
271 INJECTION SITE BRUISING 479 0.0060
272 INJECTION SITE DISCOLOURATION 75 0.0060
273 JOINT DISLOCATION 63 0.0060
274 HAEMORRHAGE SUBCUTANEOUS 21 0.0059
275 VITREOUS FLOATERS 58 0.0059
276 SKIN ODOUR ABNORMAL 23 0.0058
277 HYPERAESTHESIA 48 0.0058
278 PARAESTHESIA 915 0.0058
279 RASH PAPULAR 130 0.0058
280 FACE INJURY 22 0.0058
281 RASH VESICULAR 28 0.0058
282 MICTURITION URGENCY 66 0.0058
283 NEUROLOGICAL SYMPTOM 33 0.0058
284 MOUTH SWELLING 33 0.0057
285 NYSTAGMUS 30 0.0056
286 CRANIOCEREBRAL INJURY 17 0.0056
287 HYPERTONIA 32 0.0056
288 SKIN HYPERPIGMENTATION 48 0.0056
289 WOUND INFECTION 61 0.0056
290 MUSCLE STRAIN 48 0.0055
291 ANTINUCLEAR ANTIBODY POSITIVE 18 0.0055
292 PARTIAL SEIZURES 29 0.0055
293 TONGUE DISORDER 40 0.0055
294 DRUG RESISTANCE 142 0.0055
295 APHONIA 77 0.0055
296 HYPERHIDROSIS 703 0.0055
297 OESOPHAGEAL DISORDER 21 0.0054
298 GRIP STRENGTH DECREASED 48 0.0054
299 ENDOMETRIOSIS 26 0.0054
300 EPILEPSY 165 0.0054
301 SHOULDER OPERATION 23 0.0054
302 PHOTOPSIA 34 0.0054
303 DEFORMITY 50 0.0053
304 MUSCULOSKELETAL DISCOMFORT 91 0.0053
305 PHARYNGEAL OEDEMA 81 0.0053
306 MYDRIASIS 67 0.0052
307 SURGERY 306 0.0052
308 EYE OPERATION 24 0.0052
309 RHEUMATOID FACTOR POSITIVE 30 0.0052
310 GALLBLADDER OPERATION 21 0.0052
311 HYPOPNOEA 18 0.0052
312 INJECTION SITE ERYTHEMA 642 0.0052
313 BLINDNESS TRANSIENT 38 0.0051
314 PHARYNGEAL SWELLING 50 0.0051
315 SENSORY LOSS 41 0.0051
316 INJECTION SITE PRURITUS 340 0.0051
317 PAROSMIA 38 0.0050
318 BRAIN INJURY 50 0.0050
319 SKIN WARM 29 0.0050
320 OCULAR HYPERAEMIA 236 0.0050
321 PAPULE 35 0.0050
322 DRUG TOLERANCE 25 0.0049
323 POST-TRAUMATIC STRESS DISORDER 33 0.0049
324 FACE OEDEMA 83 0.0049
325 PRODUCT QUALITY ISSUE 668 0.0049
326 IMPAIRED GASTRIC EMPTYING 67 0.0049
327 SALIVARY HYPERSECRETION 49 0.0049
328 MUSCULOSKELETAL DISORDER 93 0.0049
329 DISCOMFORT 298 0.0049
330 HERPES VIRUS INFECTION 28 0.0049
331 APHASIA 146 0.0048
332 MUSCLE INJURY 40 0.0048
333 PEMPHIGUS 60 0.0048
334 LIMB OPERATION 23 0.0048
335 DRUG EFFECT LESS THAN EXPECTED 71 0.0048
336 DYSPHEMIA 21 0.0048
337 DRUG SPECIFIC ANTIBODY PRESENT 31 0.0048
338 TASTE DISORDER 96 0.0047
339 INCONTINENCE 50 0.0047
340 DYSGRAPHIA 31 0.0047
341 VISUAL IMPAIRMENT 583 0.0047
342 FOOD ALLERGY 36 0.0047
343 MUSCULOSKELETAL PAIN 243 0.0046
344 THERAPY NON-RESPONDER 208 0.0046
345 WRONG PRODUCT ADMINISTERED 31 0.0046
346 DUODENAL ULCER PERFORATION 34 0.0046
347 ADVERSE DRUG REACTION 410 0.0046
348 FEEDING DISORDER 92 0.0045
349 EYE INFECTION 51 0.0045
350 INJECTION SITE INJURY 25 0.0045
351 ROSACEA 21 0.0045
352 ON AND OFF PHENOMENON 25 0.0045
353 EYE PRURITUS 151 0.0045
354 DYSTONIA 87 0.0045
355 PRESYNCOPE 109 0.0045
356 BREAST CANCER STAGE III 29 0.0045
357 INTERVERTEBRAL DISC DISORDER 19 0.0044
358 PRODUCT PACKAGING ISSUE 42 0.0044
359 MUSCLE SPASMS 810 0.0044
360 GESTATIONAL DIABETES 21 0.0044
361 HYDROCEPHALUS 24 0.0044
362 URTICARIA 737 0.0044
363 GAIT INABILITY 146 0.0044
364 ODYNOPHAGIA 26 0.0044
365 SKIN ATROPHY 25 0.0043
366 SYNOVITIS 78 0.0043
367 HORMONE LEVEL ABNORMAL 21 0.0043
368 GASTROINTESTINAL MOTILITY DISORDER 23 0.0043
369 PERICARDITIS 72 0.0043
370 HYSTERECTOMY 37 0.0043
371 EXPOSURE VIA BREAST MILK 17 0.0043
372 ILEUS PARALYTIC 19 0.0043
373 DYSKINESIA 173 0.0043
374 DRY THROAT 43 0.0042
375 BACK INJURY 46 0.0042
376 SPINAL OSTEOARTHRITIS 37 0.0042
377 OROPHARYNGEAL DISCOMFORT 38 0.0042
378 SCAR 72 0.0042
379 BURSITIS 51 0.0042
380 SPINAL PAIN 49 0.0042
381 PRODUCT DISPENSING ERROR 91 0.0042
382 FAECAL INCONTINENCE 20 0.0042
383 LYMPHADENOPATHY 147 0.0041
384 INSURANCE ISSUE 63 0.0041
385 INCREASED UPPER AIRWAY SECRETION 21 0.0041
386 SINUS DISORDER 81 0.0041
387 DYSSTASIA 119 0.0041
388 LIP DRY 37 0.0041
389 SWOLLEN TONGUE 127 0.0041
390 WHEELCHAIR USER 18 0.0040
391 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 29 0.0040
392 BEDRIDDEN 53 0.0040
393 FORMICATION 28 0.0040
394 PRODUCT ADMINISTRATION ERROR 81 0.0040
395 PNEUMONIA ASPIRATION 100 0.0040
396 ANAL INCONTINENCE 36 0.0040
397 DERMATITIS CONTACT 45 0.0039
398 EXOSTOSIS 36 0.0039
399 HYPERSENSITIVITY 731 0.0039
400 MOTOR DYSFUNCTION 40 0.0039
401 SINUS CONGESTION 53 0.0039
402 ADVERSE REACTION 52 0.0039
403 FOOD POISONING 21 0.0039
404 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 188 0.0039
405 INJECTION SITE REACTION 269 0.0039
406 FEELING DRUNK 29 0.0039
407 HEMIPARESIS 66 0.0039
408 THERAPEUTIC RESPONSE UNEXPECTED 174 0.0039
409 RESPIRATORY DISORDER 116 0.0039
410 MALABSORPTION 20 0.0038
411 NONSPECIFIC REACTION 21 0.0038
412 ORAL DISORDER 28 0.0038
413 TOOTHACHE 69 0.0038
414 MULTIPLE SCLEROSIS 182 0.0038
415 MOVEMENT DISORDER 122 0.0038
416 VEIN DISORDER 19 0.0038
417 BALANCE DISORDER 328 0.0038
418 HYPOKINESIA 55 0.0038
419 NASAL DISCOMFORT 30 0.0038
420 ARTHROPOD BITE 28 0.0038
421 TENSION 23 0.0038
422 INTRACRANIAL PRESSURE INCREASED 21 0.0038
423 SKIN DISCOLOURATION 173 0.0038
424 POOR QUALITY SLEEP 81 0.0038
425 SEASONAL ALLERGY 53 0.0037
426 CYSTITIS 119 0.0037
427 IRRITABLE BOWEL SYNDROME 80 0.0037
428 PALPITATIONS 436 0.0037
429 SLEEP APNOEA SYNDROME 71 0.0037
430 VISUAL ACUITY REDUCED 123 0.0037
431 INJECTION SITE INDURATION 48 0.0037
432 MULTIPLE ALLERGIES 29 0.0037
433 EYE IRRITATION 212 0.0037
434 INTERVERTEBRAL DISC DEGENERATION 34 0.0037
435 PRESCRIBED OVERDOSE 71 0.0037
436 ANXIETY 1041 0.0037
437 FEELING OF DESPAIR 17 0.0036
438 DIZZINESS 1813 0.0036
439 HYPERVENTILATION 21 0.0036
440 INITIAL INSOMNIA 37 0.0036
441 FLUID INTAKE REDUCED 18 0.0036
442 MUSCLE RIGIDITY 43 0.0036
443 PHOTOSENSITIVITY REACTION 59 0.0036
444 PRODUCT LABEL ISSUE 24 0.0035
445 FEELING ABNORMAL 847 0.0035
446 FOLLICULITIS 37 0.0035
447 UPPER-AIRWAY COUGH SYNDROME 29 0.0035
448 CHEILITIS 19 0.0035
449 PRODUCT USE IN UNAPPROVED INDICATION 866 0.0035
450 ROAD TRAFFIC ACCIDENT 146 0.0035
451 POST PROCEDURAL COMPLICATION 67 0.0035
452 IMPAIRED QUALITY OF LIFE 50 0.0035
453 PRODUCT PHYSICAL ISSUE 70 0.0035
454 NERVE COMPRESSION 32 0.0035
455 INJECTION SITE IRRITATION 44 0.0035
456 URINARY TRACT INFECTION 589 0.0034
457 FEELING HOT 211 0.0034
458 RED BLOOD CELL SEDIMENTATION RATE INCREASED 38 0.0034
459 ASTHENIA 1287 0.0034
460 SINUSITIS 350 0.0034
461 NIGHT SWEATS 110 0.0034
462 FEELING OF BODY TEMPERATURE CHANGE 20 0.0034
463 TEMPERATURE INTOLERANCE 35 0.0034
464 SCOLIOSIS 21 0.0034
465 ORAL DISCOMFORT 47 0.0034
466 OROPHARYNGEAL PAIN 313 0.0034
467 MIDDLE INSOMNIA 63 0.0034
468 POST PROCEDURAL INFECTION 27 0.0033
469 NERVOUS SYSTEM DISORDER 103 0.0033
470 GASTROOESOPHAGEAL REFLUX DISEASE 265 0.0033
471 LIQUID PRODUCT PHYSICAL ISSUE 24 0.0033
472 DISABILITY 65 0.0033
473 ACTIVITIES OF DAILY LIVING IMPAIRED 65 0.0033
474 BRAIN NEOPLASM 30 0.0033
475 UNEVALUABLE EVENT 247 0.0033
476 BLINDNESS UNILATERAL 46 0.0033
477 ERYTHEMA 670 0.0033
478 INJECTION SITE WARMTH 67 0.0033
479 ANOSMIA 47 0.0032
480 PALLOR 88 0.0032
481 SKIN SWELLING 28 0.0032
482 HEAD INJURY 102 0.0032
483 SYSTEMIC LUPUS ERYTHEMATOSUS 113 0.0032
484 PREMATURE LABOUR 18 0.0032
485 COLD SWEAT 56 0.0032
486 THROAT IRRITATION 142 0.0032
487 INFLAMMATION 163 0.0032
488 INTERVERTEBRAL DISC PROTRUSION 69 0.0032
489 SCAB 36 0.0032
490 TREMOR 522 0.0031
491 CYST 39 0.0031
492 BODY TEMPERATURE INCREASED 64 0.0031
493 PROCEDURAL COMPLICATION 24 0.0031
494 INJECTION SITE HAEMORRHAGE 250 0.0031
495 PAIN 1921 0.0031
496 JOINT STIFFNESS 82 0.0031
497 HEMIPLEGIA 26 0.0031
498 AMNESIA 203 0.0031
499 C-REACTIVE PROTEIN ABNORMAL 20 0.0031
500 SECRETION DISCHARGE 39 0.0031
501 WOUND 87 0.0031
502 DRUG EFFECT INCOMPLETE 113 0.0031
503 PROCTALGIA 20 0.0031
504 CEREBRAL DISORDER 23 0.0031
505 SEIZURE 359 0.0031
506 DYSURIA 114 0.0031
507 CHEST DISCOMFORT 317 0.0031
508 MENISCUS INJURY 19 0.0031
509 MOBILITY DECREASED 221 0.0031
510 FOOT DEFORMITY 34 0.0031
511 RIB FRACTURE 63 0.0031
512 EYE INFLAMMATION 29 0.0030
513 LOCAL SWELLING 53 0.0030
514 MEMORY IMPAIRMENT 417 0.0030
515 SKIN LACERATION 33 0.0030
516 WALKING AID USER 20 0.0030
517 NASAL DRYNESS 19 0.0030
518 SNEEZING 68 0.0030
519 RESTLESS LEGS SYNDROME 55 0.0030
520 BLINDNESS 123 0.0030
521 GINGIVAL PAIN 24 0.0030
522 ANAPHYLACTIC REACTION 164 0.0030
523 UPPER RESPIRATORY TRACT INFECTION 137 0.0030
524 PRURITUS GENERALISED 64 0.0030
525 IMMUNE SYSTEM DISORDER 39 0.0030
526 EATING DISORDER 63 0.0030
527 GAIT DISTURBANCE 564 0.0029
528 ACCIDENTAL EXPOSURE TO PRODUCT 303 0.0029
529 CARPAL TUNNEL SYNDROME 41 0.0029
530 LIMB DISCOMFORT 90 0.0029
531 HYPERCHOLESTEROLAEMIA 28 0.0029
532 MENSTRUAL DISORDER 24 0.0029
533 MENTAL IMPAIRMENT 70 0.0029
534 DIZZINESS POSTURAL 28 0.0029
535 RASH ERYTHEMATOUS 138 0.0029
536 VIRAL INFECTION 96 0.0029
537 BRADYKINESIA 17 0.0029
538 VITAMIN D DEFICIENCY 28 0.0029
539 LACERATION 27 0.0029
540 INFUSION SITE SWELLING 18 0.0029
541 EAR INFECTION 76 0.0029
542 BIPOLAR DISORDER 31 0.0028
543 ILLNESS 293 0.0028
544 PRODUCT COMPLAINT 72 0.0028
545 NAUSEA 2245 0.0028
546 TOOTH FRACTURE 31 0.0028
547 CONTRAINDICATED PRODUCT ADMINISTERED 85 0.0028
548 RESPIRATORY TRACT INFECTION 73 0.0028
549 INFUSION SITE PAIN 36 0.0028
550 LETHARGY 160 0.0028
551 WEIGHT FLUCTUATION 29 0.0028
552 DYSPNOEA 1561 0.0028
553 NAIL DISORDER 24 0.0027
554 THINKING ABNORMAL 51 0.0027
555 HERPES ZOSTER 157 0.0027
556 ALOPECIA 536 0.0027
557 DISORIENTATION 108 0.0027
558 IMMUNOSUPPRESSION 24 0.0027
559 CHOLECYSTECTOMY 31 0.0027
560 KIDNEY INFECTION 53 0.0027
561 DECUBITUS ULCER 22 0.0027
562 MYALGIA 459 0.0027
563 APNOEA 21 0.0027
564 SCIATICA 43 0.0027
565 THERAPY PARTIAL RESPONDER 42 0.0027
566 THERMAL BURN 19 0.0027
567 SKIN INFECTION 30 0.0027
568 BRONCHIECTASIS 18 0.0027
569 MATERNAL EXPOSURE DURING PREGNANCY 238 0.0027
570 GENERAL SYMPTOM 20 0.0027
571 HEART RATE INCREASED 264 0.0027
572 DISTURBANCE IN ATTENTION 143 0.0026
573 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 45 0.0026
574 KNEE OPERATION 26 0.0026
575 CONJUNCTIVITIS 49 0.0026
576 PERIPHERAL COLDNESS 36 0.0026
577 APPLICATION SITE VESICLES 17 0.0026
578 ADVERSE EVENT 241 0.0026
579 RETINAL DETACHMENT 24 0.0026
580 RASH PUSTULAR 19 0.0026
581 INCREASED TENDENCY TO BRUISE 24 0.0026
582 AGEUSIA 65 0.0026
583 INSOMNIA 688 0.0026
584 RESPIRATORY TRACT CONGESTION 41 0.0026
585 THIRST 46 0.0026
586 ASPHYXIA 21 0.0026
587 COGNITIVE DISORDER 120 0.0026
588 MYOSITIS 23 0.0026
589 PAIN OF SKIN 69 0.0026
590 DEAFNESS 67 0.0026
591 RASH 1116 0.0026
592 FEELING COLD 71 0.0025
593 LIGAMENT SPRAIN 25 0.0025
594 LOSS OF CONSCIOUSNESS 323 0.0025
595 ABORTION SPONTANEOUS 100 0.0025
596 INFLUENZA 278 0.0025
597 IRON DEFICIENCY ANAEMIA 23 0.0025
598 ECCHYMOSIS 17 0.0025
599 OSTEOARTHRITIS 105 0.0025
600 FRUSTRATION TOLERANCE DECREASED 20 0.0025
601 BACK DISORDER 40 0.0025
602 DYSGEUSIA 182 0.0024
603 RASH GENERALISED 63 0.0024
604 HELICOBACTER INFECTION 25 0.0024
605 SLEEP DISORDER 171 0.0024
606 FATIGUE 1878 0.0024
607 CELLULITIS 121 0.0024
608 PSORIATIC ARTHROPATHY 97 0.0024
609 HEART RATE IRREGULAR 54 0.0024
610 POLLAKIURIA 99 0.0024
611 RENAL PAIN 25 0.0024
612 RHINITIS 19 0.0024
613 VITAMIN D DECREASED 20 0.0023
614 PRURITUS 898 0.0023
615 BLISTER 131 0.0023
616 FLUSHING 235 0.0023
617 OPTIC NEURITIS 21 0.0023
618 HAEMORRHOIDS 45 0.0023
619 ORAL HERPES 45 0.0023
620 DEPRESSION 523 0.0023
621 CEREBROVASCULAR ACCIDENT 388 0.0023
622 CRYING 83 0.0023
623 ATAXIA 27 0.0023
624 DENTAL CARIES 25 0.0023
625 TYPE 2 DIABETES MELLITUS 76 0.0023
626 BACK PAIN 524 0.0023
627 OBSTRUCTIVE AIRWAYS DISORDER 25 0.0022
628 CHILLS 263 0.0022
629 MALAISE 983 0.0022
630 LOWER LIMB FRACTURE 43 0.0022
631 FEAR 60 0.0022
632 DERMATITIS ALLERGIC 28 0.0022
633 TRANSIENT ISCHAEMIC ATTACK 75 0.0022
634 COVID-19 390 0.0022
635 BOWEL MOVEMENT IRREGULARITY 17 0.0022
636 FALL 736 0.0022
637 PNEUMOTHORAX 35 0.0022
638 MULTIPLE SCLEROSIS RELAPSE 151 0.0022
639 CONSTIPATION 477 0.0022
640 CHEST PAIN 404 0.0022
641 ACCIDENT 26 0.0022
642 PELVIC PAIN 39 0.0021
643 WEIGHT DECREASED 599 0.0021
644 APPENDICITIS 20 0.0021
645 THERAPY CHANGE 21 0.0021
646 SOMNOLENCE 428 0.0021
647 GENERALISED TONIC-CLONIC SEIZURE 35 0.0021
648 FOOT FRACTURE 40 0.0021
649 EXPIRED PRODUCT ADMINISTERED 70 0.0021
650 ABASIA 52 0.0021
651 LIMB INJURY 57 0.0021
652 IMMUNODEFICIENCY 31 0.0021
653 SUDDEN DEATH 22 0.0021
654 TREATMENT FAILURE 172 0.0021
655 NASAL CONGESTION 122 0.0021
656 MUSCULOSKELETAL CHEST PAIN 32 0.0021
657 HYPOTHYROIDISM 66 0.0021
658 RETCHING 44 0.0021
659 DERMATITIS 43 0.0021
660 TOOTH INFECTION 27 0.0020
661 THERAPY CESSATION 105 0.0020
662 PYREXIA 707 0.0020
663 KNEE ARTHROPLASTY 43 0.0020
664 VENTRICULAR EXTRASYSTOLES 21 0.0020
665 SUICIDAL IDEATION 185 0.0020
666 INCORRECT DOSE ADMINISTERED 461 0.0020
667 THYROID DISORDER 31 0.0020
668 GLOSSODYNIA 45 0.0020
669 ORAL PAIN 45 0.0020
670 SYNCOPE 201 0.0020
671 HIATUS HERNIA 26 0.0020
672 GASTROINTESTINAL PAIN 22 0.0020
673 ASTHMA 225 0.0020
674 LUPUS-LIKE SYNDROME 18 0.0020
675 TOOTH DISORDER 44 0.0020
676 RHINORRHOEA 127 0.0020
677 SLUGGISHNESS 20 0.0020
678 CANDIDA INFECTION 33 0.0020
679 DEPRESSED MOOD 103 0.0019
680 ROTATOR CUFF SYNDROME 25 0.0019
681 OBESITY 31 0.0019
682 ANAPHYLACTIC SHOCK 50 0.0019
683 GASTROENTERITIS VIRAL 35 0.0019
684 DEATH 1670 0.0019
685 QUALITY OF LIFE DECREASED 26 0.0019
686 EXPOSURE DURING PREGNANCY 120 0.0019
687 DRUG EFFECT DECREASED 104 0.0019
688 BLOOD PRESSURE INCREASED 295 0.0019
689 VOMITING 906 0.0019
690 GLAUCOMA 37 0.0019
691 RASH PRURITIC 104 0.0019
692 NERVOUSNESS 100 0.0019
693 ABORTION INDUCED 18 0.0019
694 PAIN IN EXTREMITY 563 0.0019
695 APPLICATION SITE PAIN 42 0.0019
696 GASTROINTESTINAL INFECTION 17 0.0019
697 HYPOACUSIS 81 0.0019
698 MALNUTRITION 21 0.0019
699 TENDONITIS 29 0.0019
700 WHEEZING 111 0.0019
701 C-REACTIVE PROTEIN INCREASED 68 0.0019
702 LYMPHOCYTE COUNT DECREASED 33 0.0019
703 BRONCHITIS 138 0.0019
704 DRUG INTOLERANCE 180 0.0019
705 HAEMATOMA 48 0.0019
706 HYPERSOMNIA 53 0.0018
707 PHARYNGITIS STREPTOCOCCAL 20 0.0018
708 ECONOMIC PROBLEM 28 0.0018
709 ACNE 140 0.0018
710 MYOCLONUS 22 0.0018
711 MACULAR DEGENERATION 22 0.0018
712 GRAND MAL CONVULSION 17 0.0018
713 INTERNAL HAEMORRHAGE 21 0.0018
714 NEOPLASM 21 0.0018
715 JOINT INJURY 39 0.0018
716 CENTRAL NERVOUS SYSTEM LESION 25 0.0018
717 GASTROINTESTINAL DISORDER 162 0.0018
718 ARTHROPATHY 100 0.0018
719 COORDINATION ABNORMAL 25 0.0018
720 INJECTION SITE EXTRAVASATION 22 0.0018
721 PHARYNGITIS 22 0.0018
722 HYPOPHAGIA 45 0.0018
723 HYPERLIPIDAEMIA 21 0.0018
724 HAND DEFORMITY 23 0.0018
725 EMOTIONAL DISORDER 54 0.0017
726 POISONING 22 0.0017
727 CONFUSIONAL STATE 283 0.0017
728 DRUG ERUPTION 31 0.0017
729 BLOOD CHOLESTEROL INCREASED 81 0.0017
730 DEVICE DIFFICULT TO USE 115 0.0017
731 INCORRECT ROUTE OF DRUG ADMINISTRATION 62 0.0017
732 NOCTURIA 21 0.0017
733 ABDOMINAL PAIN UPPER 356 0.0017
734 DYSPEPSIA 170 0.0017
735 EYE HAEMORRHAGE 23 0.0017
736 LIVER FUNCTION TEST INCREASED 37 0.0017
737 NO THERAPEUTIC RESPONSE 21 0.0017
738 FUNGAL INFECTION 57 0.0017
739 ANGINA PECTORIS 49 0.0017
740 HERNIA 33 0.0017
741 SKIN REACTION 24 0.0017
742 NASOPHARYNGITIS 314 0.0017
743 CONDITION AGGRAVATED 514 0.0017
744 INFUSION RELATED REACTION 112 0.0017
745 TACHYCARDIA 150 0.0017
746 STATUS EPILEPTICUS 19 0.0017
747 HEART RATE DECREASED 59 0.0017
748 DECREASED ACTIVITY 18 0.0017
749 BACTERIAL INFECTION 31 0.0017
750 DIVERTICULITIS 46 0.0017
751 RASH MACULAR 58 0.0017
752 OSTEOPOROSIS 68 0.0017
753 HAIR TEXTURE ABNORMAL 22 0.0016
754 PRODUCT USE ISSUE 307 0.0016
755 ABDOMINAL DISCOMFORT 274 0.0016
756 BLOOD URINE PRESENT 31 0.0016
757 INJURY ASSOCIATED WITH DEVICE 33 0.0016
758 BLOOD PRESSURE DECREASED 107 0.0016
759 PRESCRIBED UNDERDOSE 32 0.0016
760 NEOPLASM MALIGNANT 107 0.0016
761 CYANOSIS 25 0.0016
762 WRIST FRACTURE 19 0.0016
763 STOMATITIS 96 0.0016
764 ULCER 25 0.0016
765 PERIPHERAL SWELLING 241 0.0016
766 IRRITABILITY 94 0.0016
767 WEIGHT INCREASED 349 0.0016
768 UPPER LIMB FRACTURE 31 0.0016
769 CEREBRAL INFARCTION 38 0.0016
770 IMPAIRED HEALING 51 0.0016
771 PRODUCTIVE COUGH 74 0.0015
772 MOOD ALTERED 42 0.0015
773 SKIN LESION 42 0.0015
774 BLOOD POTASSIUM DECREASED 46 0.0015
775 INTENTIONAL PRODUCT USE ISSUE 134 0.0015
776 CATARACT 91 0.0015
777 MOUTH ULCERATION 32 0.0015
778 COUGH 425 0.0015
779 ARTHRALGIA 630 0.0015
780 ANGIOEDEMA 67 0.0015
781 OEDEMA 82 0.0015
782 DYSMENORRHOEA 20 0.0015
783 HALLUCINATION 113 0.0015
784 INCORRECT DOSE ADMINISTERED BY DEVICE 39 0.0015
785 HOT FLUSH 112 0.0015
786 PNEUMONIA 481 0.0015
787 PROCEDURAL PAIN 41 0.0015
788 HYPERTENSION 313 0.0015
789 PRODUCT DOSE OMISSION 96 0.0015
790 FEELING JITTERY 28 0.0015
791 PRODUCT USE COMPLAINT 23 0.0015
792 STAPHYLOCOCCAL INFECTION 48 0.0015
793 SKIN BURNING SENSATION 104 0.0015
794 PULMONARY CONGESTION 19 0.0014
795 BREAST CANCER FEMALE 38 0.0014
796 ANKLE FRACTURE 22 0.0014
797 SKIN HAEMORRHAGE 21 0.0014
798 INFECTION 205 0.0014
799 NEUROPATHY PERIPHERAL 134 0.0014
800 BLOOD PRESSURE ABNORMAL 28 0.0014
801 PRODUCT TASTE ABNORMAL 19 0.0014
802 INTENTIONAL DOSE OMISSION 40 0.0014
803 MENTAL DISORDER 61 0.0014
804 DECREASED APPETITE 325 0.0014
805 RESPIRATORY FAILURE 102 0.0014
806 SPINAL FRACTURE 28 0.0014
807 DRUG TOXICITY 19 0.0014
808 ARTHRITIS 109 0.0014
809 WHITE BLOOD CELL COUNT INCREASED 53 0.0014
810 CONVULSION 79 0.0014
811 RESPIRATORY DISTRESS 38 0.0014
812 CHOLELITHIASIS 45 0.0014
813 HIP ARTHROPLASTY 21 0.0014
814 FREQUENT BOWEL MOVEMENTS 37 0.0014
815 GASTRIC ULCER 26 0.0014
816 HUNGER 19 0.0014
817 UNRESPONSIVE TO STIMULI 35 0.0014
818 HAEMATURIA 46 0.0013
819 RESPIRATORY ARREST 37 0.0013
820 INJURY 94 0.0013
821 HOSPITALISATION 205 0.0013
822 BONE PAIN 78 0.0013
823 GASTRITIS 35 0.0013
824 THERAPY INTERRUPTED 95 0.0013
825 DEMENTIA 37 0.0013
826 OXYGEN SATURATION DECREASED 74 0.0013
827 RHEUMATOID ARTHRITIS 149 0.0013
828 GASTROENTERITIS 19 0.0013
829 PREMATURE BABY 39 0.0013
830 BLOOD PRESSURE FLUCTUATION 31 0.0013
831 LUNG DISORDER 63 0.0013
832 FRACTURE 24 0.0013
833 FOETAL EXPOSURE DURING PREGNANCY 103 0.0013
834 DEHYDRATION 169 0.0013
835 UNDERDOSE 92 0.0013
836 ABSCESS 20 0.0013
837 PULMONARY FIBROSIS 24 0.0012
838 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 225 0.0012
839 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
840 HIP FRACTURE 40 0.0012
841 DRUG DOSE OMISSION BY DEVICE 97 0.0012
842 CARDIAC DISORDER 115 0.0012
843 ABDOMINAL DISTENSION 128 0.0012
844 INTENTIONAL PRODUCT MISUSE 107 0.0012
845 APPLICATION SITE ERYTHEMA 32 0.0012
846 OSTEOMYELITIS 22 0.0012
847 ARRHYTHMIA 57 0.0012
848 LOCALISED INFECTION 29 0.0012
849 INTESTINAL OBSTRUCTION 45 0.0012
850 LOWER RESPIRATORY TRACT INFECTION 54 0.0012
851 SKIN EXFOLIATION 100 0.0012
852 CEREBRAL HAEMORRHAGE 42 0.0012
853 COMPLICATION ASSOCIATED WITH DEVICE 17 0.0012
854 SEPSIS 130 0.0012
855 OVERDOSE 251 0.0012
856 SKIN CANCER 25 0.0012
857 TOOTH LOSS 24 0.0012
858 ANGER 39 0.0012
859 CLOSTRIDIUM DIFFICILE INFECTION 25 0.0011
860 DEPRESSED LEVEL OF CONSCIOUSNESS 45 0.0011
861 ILL-DEFINED DISORDER 69 0.0011
862 MEDICATION ERROR 63 0.0011
863 DIARRHOEA 728 0.0011
864 ABNORMAL DREAMS 31 0.0011
865 WITHDRAWAL SYNDROME 47 0.0011
866 SKIN IRRITATION 51 0.0011
867 PARANOIA 19 0.0011
868 PRODUCT AVAILABILITY ISSUE 25 0.0011
869 PRODUCT DOSE OMISSION ISSUE 319 0.0011
870 GENERAL PHYSICAL HEALTH DETERIORATION 125 0.0011
871 BLOOD CREATINE PHOSPHOKINASE INCREASED 31 0.0011
872 ECZEMA 56 0.0011
873 DELIRIUM 37 0.0011
874 GALLBLADDER DISORDER 19 0.0011
875 APPLICATION SITE PRURITUS 24 0.0011
876 CIRCULATORY COLLAPSE 18 0.0011
877 PRODUCT PRESCRIBING ISSUE 23 0.0011
878 ABDOMINAL PAIN 243 0.0010
879 FLUID RETENTION 53 0.0010
880 ACUTE RESPIRATORY FAILURE 20 0.0010
881 HAEMORRHAGE 108 0.0010
882 BREAST CANCER 96 0.0010
883 RECTAL HAEMORRHAGE 44 0.0010
884 LIVER INJURY 25 0.0010
885 COLITIS ULCERATIVE 45 0.0010
886 NEEDLE ISSUE 29 0.0010
887 TARDIVE DYSKINESIA 28 0.0010
888 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
889 RENAL DISORDER 46 0.0010
890 SKIN FISSURES 19 0.0010
891 GASTRIC DISORDER 33 0.0010
892 HEPATIC CIRRHOSIS 18 0.0010
893 HYPOTENSION 190 0.0009
894 SEROTONIN SYNDROME 18 0.0009
895 FEMUR FRACTURE 29 0.0009
896 ERUCTATION 18 0.0009
897 PRODUCT PRESCRIBING ERROR 22 0.0009
898 DRY SKIN 123 0.0009
899 HALLUCINATION, VISUAL 19 0.0009
900 AGITATION 66 0.0009
901 HEPATIC ENZYME INCREASED 61 0.0009
902 JOINT SWELLING 108 0.0009
903 PULMONARY EMBOLISM 85 0.0009
904 OEDEMA PERIPHERAL 109 0.0009
905 ATRIAL FIBRILLATION 87 0.0009
906 SKIN ULCER 23 0.0009
907 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 30 0.0009
908 EXPOSURE VIA SKIN CONTACT 23 0.0009
909 ABNORMAL BEHAVIOUR 35 0.0009
910 THROMBOSIS 71 0.0009
911 DEVICE ISSUE 79 0.0009
912 RESTLESSNESS 32 0.0009
913 ABDOMINAL PAIN LOWER 22 0.0009
914 CARDIOVASCULAR DISORDER 22 0.0009
915 COMA 41 0.0009
916 HAEMATOCRIT DECREASED 17 0.0009
917 DRUG ADMINISTRATION ERROR 26 0.0008
918 MOOD SWINGS 27 0.0008
919 RED BLOOD CELL COUNT DECREASED 24 0.0008
920 SEPTIC SHOCK 36 0.0008
921 DYSPNOEA EXERTIONAL 31 0.0008
922 LABORATORY TEST ABNORMAL 24 0.0008
923 PRODUCT DOSE OMISSION IN ERROR 23 0.0008
924 EMOTIONAL DISTRESS 96 0.0008
925 MENTAL STATUS CHANGES 22 0.0008
926 PSYCHOTIC DISORDER 23 0.0008
927 DRUG INTERACTION 122 0.0008
928 GAMMA-GLUTAMYLTRANSFERASE INCREASED 17 0.0008
929 CHROMATURIA 17 0.0008
930 MULTIPLE ORGAN DYSFUNCTION SYNDROME 21 0.0007
931 DEVICE MALFUNCTION 51 0.0007
932 HEPATIC FUNCTION ABNORMAL 27 0.0007
933 EPISTAXIS 54 0.0007
934 LIVER DISORDER 32 0.0007
935 BRADYCARDIA 38 0.0007
936 FLATULENCE 40 0.0007
937 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
938 DIABETES MELLITUS 53 0.0007
939 DEEP VEIN THROMBOSIS 45 0.0007
940 DEVICE DISLOCATION 30 0.0007
941 DEVICE BREAKAGE 28 0.0007
942 EXTRAPYRAMIDAL DISORDER 17 0.0007
943 DERMATITIS ATOPIC 36 0.0007
944 CARDIO-RESPIRATORY ARREST 27 0.0006
945 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
946 HYPOKALAEMIA 29 0.0006
947 HYPOXIA 22 0.0006
948 TOXICITY TO VARIOUS AGENTS 103 0.0006
949 COLITIS 23 0.0006
950 CARDIAC ARREST 50 0.0006
951 PANCREATITIS 32 0.0006
952 VAGINAL HAEMORRHAGE 26 0.0006
953 HYPONATRAEMIA 33 0.0006
954 BLOOD GLUCOSE DECREASED 28 0.0006
955 RHABDOMYOLYSIS 24 0.0006
956 MYOCARDIAL INFARCTION 98 0.0006
957 HYPOGLYCAEMIA 27 0.0006
958 ANAEMIA 103 0.0005
959 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 28 0.0005
960 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 38 0.0005
961 DEVICE USE ERROR 18 0.0005
962 LEUKOPENIA 25 0.0005
963 DRUG EXPOSURE DURING PREGNANCY 17 0.0005
964 EXTRA DOSE ADMINISTERED 20 0.0005
965 TREATMENT NONCOMPLIANCE 27 0.0005
966 DRUG DOSE OMISSION 79 0.0005
967 PULMONARY OEDEMA 21 0.0005
968 DRUG ABUSE 39 0.0005
969 PSORIASIS 61 0.0005
970 CHRONIC KIDNEY DISEASE 35 0.0005
971 CARDIAC FAILURE 36 0.0004
972 BLOOD CREATININE INCREASED 29 0.0004
973 AGGRESSION 22 0.0004
974 DRUG WITHDRAWAL SYNDROME 37 0.0004
975 HAEMOGLOBIN DECREASED 43 0.0004
976 PLEURAL EFFUSION 25 0.0004
977 PRODUCT SUBSTITUTION ISSUE 23 0.0004
978 HAEMATOCHEZIA 22 0.0004
979 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
980 NO ADVERSE EVENT 71 0.0004
981 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 18 0.0004
982 RENAL FAILURE 46 0.0003
983 SUICIDE ATTEMPT 20 0.0003
984 CARDIAC FAILURE CONGESTIVE 26 0.0003
985 BLOOD GLUCOSE INCREASED 60 0.0003
986 RENAL IMPAIRMENT 23 0.0003
987 ACUTE KIDNEY INJURY 40 0.0003
988 PLATELET COUNT DECREASED 24 0.0002
989 DISEASE PROGRESSION 25 0.0002
990 DRUG DEPENDENCE 25 0.0002